Decreased plasma adiponectin concentration in major depression
Roberto Leo1, Giorgio Di Lorenzo, Manfredi Tesauro
1Department of Internal Medicine, University of Rome Tor Vergata, School of Medicine, Rome, Italy. rtoleo@tiscali.it
Neuroscience Letters
|September 16, 2006
Summary
This study found lower plasma adiponectin levels in major depression patients. Reduced adiponectin concentrations correlated with increased depression severity, suggesting a link between adiponectin and major depressive disorder.
Area of Science:
- Endocrinology
- Psychiatry
- Cardiovascular Disease Risk Factors
Background:
- Adiponectin, an adipose-derived protein, is linked to metabolic syndrome and cardiovascular disease risk.
- The relationship between adiponectin and major depression remains largely unexplored.
- This study investigates adiponectin levels in patients with first-episode major depression.
Purpose of the Study:
- To evaluate plasma adiponectin levels in drug-naïve major depression patients.
- To compare adiponectin levels between major depression patients and healthy controls.
- To determine the correlation between adiponectin levels and depression severity.
Main Methods:
- Assessed plasma adiponectin concentrations in 32 first-episode drug-naïve major depression patients.
- Included 32 matched healthy subjects as controls.
- Utilized the Hamilton Depression Rating Scale (HAM-D) to assess depression severity.
Main Results:
- Major depression patients exhibited significantly lower plasma adiponectin levels compared to controls (P<0.01).
- Adiponectin levels showed a significant positive correlation with depression severity (rho=0.83, P<0.001).
- No conventional cardiovascular risk factors were present in the patient group.
Conclusions:
- Decreased plasma adiponectin concentrations are associated with major depression.
- Adiponectin reduction may be linked to the severity of major depressive disorder.
- Further research is warranted to explore the role of adiponectin in depression pathophysiology.
Related Concept Videos
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...